The Development, Implementation, and Evaluation of a Pharmacist-Managed Therapeutic Drug Monitoring (TDM) Service for Vancomycin—A Pilot Study

Background: In recent years, pharmacists in Australia have been able to expand their scope to include the provision of a range of services. Although evidence has demonstrated the benefits of pharmacist-managed TDM services, recent studies have shown that these services are not prominent within Austr...

Full description

Bibliographic Details
Main Authors: Paul Firman, Ken-Soon Tan, Alexandra Clavarino, Meng-Wong Taing, Sally Dixon, Helender Singh, Karen Whitfield
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Pharmacy
Subjects:
Online Access:https://www.mdpi.com/2226-4787/10/6/173
_version_ 1797455637114781696
author Paul Firman
Ken-Soon Tan
Alexandra Clavarino
Meng-Wong Taing
Sally Dixon
Helender Singh
Karen Whitfield
author_facet Paul Firman
Ken-Soon Tan
Alexandra Clavarino
Meng-Wong Taing
Sally Dixon
Helender Singh
Karen Whitfield
author_sort Paul Firman
collection DOAJ
description Background: In recent years, pharmacists in Australia have been able to expand their scope to include the provision of a range of services. Although evidence has demonstrated the benefits of pharmacist-managed TDM services, recent studies have shown that these services are not prominent within Australia and that the current TDM workflow may not be optimal. Methods: An interventional pilot study was conducted of a pharmacist-managed TDM program for vancomycin at a tertiary hospital in Australia. Results: In total, 15 pharmacists participated in the program. They performed 50.5% of the medication-related pathology over the intervention period. Pharmacist involvement in the TDM process was more likely to lead to appropriate TDM sample collection (OR 87.1; 95% CI = 11.5, 661.1) and to an appropriate dose adjustment (OR 19.1; 95% CI = 1.7, 213.5). Pharmacists demonstrated increased confidence after the education and credentialling package was provided. Conclusions: This study demonstrated that a credentialling package for pharmacists can improve knowledge, skills, and confidence around the provision of pharmacist-managed TDM services for vancomycin. This may lead to the evolution of different roles and workflows enabling pharmacists to contribute more efficiently to improving medication safety and use.
first_indexed 2024-03-09T15:57:09Z
format Article
id doaj.art-272c11a2f7384df2bd02734fb78c9c69
institution Directory Open Access Journal
issn 2226-4787
language English
last_indexed 2024-03-09T15:57:09Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Pharmacy
spelling doaj.art-272c11a2f7384df2bd02734fb78c9c692023-11-24T17:23:40ZengMDPI AGPharmacy2226-47872022-12-0110617310.3390/pharmacy10060173The Development, Implementation, and Evaluation of a Pharmacist-Managed Therapeutic Drug Monitoring (TDM) Service for Vancomycin—A Pilot StudyPaul Firman0Ken-Soon Tan1Alexandra Clavarino2Meng-Wong Taing3Sally Dixon4Helender Singh5Karen Whitfield6School of Pharmacy, The University of Queensland, Woolloongabba, QLD 4102, AustraliaSchool of Medicine, Griffith University, Gold Coast, QLD 4222, AustraliaSchool of Public Health, The University of Queensland, Saint Lucia, QLD 4072, AustraliaSchool of Pharmacy, The University of Queensland, Woolloongabba, QLD 4102, AustraliaLogan Hospital, Meadowbrook, QLD 4131, AustraliaLogan Hospital, Meadowbrook, QLD 4131, AustraliaSchool of Pharmacy, The University of Queensland, Woolloongabba, QLD 4102, AustraliaBackground: In recent years, pharmacists in Australia have been able to expand their scope to include the provision of a range of services. Although evidence has demonstrated the benefits of pharmacist-managed TDM services, recent studies have shown that these services are not prominent within Australia and that the current TDM workflow may not be optimal. Methods: An interventional pilot study was conducted of a pharmacist-managed TDM program for vancomycin at a tertiary hospital in Australia. Results: In total, 15 pharmacists participated in the program. They performed 50.5% of the medication-related pathology over the intervention period. Pharmacist involvement in the TDM process was more likely to lead to appropriate TDM sample collection (OR 87.1; 95% CI = 11.5, 661.1) and to an appropriate dose adjustment (OR 19.1; 95% CI = 1.7, 213.5). Pharmacists demonstrated increased confidence after the education and credentialling package was provided. Conclusions: This study demonstrated that a credentialling package for pharmacists can improve knowledge, skills, and confidence around the provision of pharmacist-managed TDM services for vancomycin. This may lead to the evolution of different roles and workflows enabling pharmacists to contribute more efficiently to improving medication safety and use.https://www.mdpi.com/2226-4787/10/6/173clinical pharmacytherapeutic drug monitoringvancomycinexpanded scope pharmacist
spellingShingle Paul Firman
Ken-Soon Tan
Alexandra Clavarino
Meng-Wong Taing
Sally Dixon
Helender Singh
Karen Whitfield
The Development, Implementation, and Evaluation of a Pharmacist-Managed Therapeutic Drug Monitoring (TDM) Service for Vancomycin—A Pilot Study
Pharmacy
clinical pharmacy
therapeutic drug monitoring
vancomycin
expanded scope pharmacist
title The Development, Implementation, and Evaluation of a Pharmacist-Managed Therapeutic Drug Monitoring (TDM) Service for Vancomycin—A Pilot Study
title_full The Development, Implementation, and Evaluation of a Pharmacist-Managed Therapeutic Drug Monitoring (TDM) Service for Vancomycin—A Pilot Study
title_fullStr The Development, Implementation, and Evaluation of a Pharmacist-Managed Therapeutic Drug Monitoring (TDM) Service for Vancomycin—A Pilot Study
title_full_unstemmed The Development, Implementation, and Evaluation of a Pharmacist-Managed Therapeutic Drug Monitoring (TDM) Service for Vancomycin—A Pilot Study
title_short The Development, Implementation, and Evaluation of a Pharmacist-Managed Therapeutic Drug Monitoring (TDM) Service for Vancomycin—A Pilot Study
title_sort development implementation and evaluation of a pharmacist managed therapeutic drug monitoring tdm service for vancomycin a pilot study
topic clinical pharmacy
therapeutic drug monitoring
vancomycin
expanded scope pharmacist
url https://www.mdpi.com/2226-4787/10/6/173
work_keys_str_mv AT paulfirman thedevelopmentimplementationandevaluationofapharmacistmanagedtherapeuticdrugmonitoringtdmserviceforvancomycinapilotstudy
AT kensoontan thedevelopmentimplementationandevaluationofapharmacistmanagedtherapeuticdrugmonitoringtdmserviceforvancomycinapilotstudy
AT alexandraclavarino thedevelopmentimplementationandevaluationofapharmacistmanagedtherapeuticdrugmonitoringtdmserviceforvancomycinapilotstudy
AT mengwongtaing thedevelopmentimplementationandevaluationofapharmacistmanagedtherapeuticdrugmonitoringtdmserviceforvancomycinapilotstudy
AT sallydixon thedevelopmentimplementationandevaluationofapharmacistmanagedtherapeuticdrugmonitoringtdmserviceforvancomycinapilotstudy
AT helendersingh thedevelopmentimplementationandevaluationofapharmacistmanagedtherapeuticdrugmonitoringtdmserviceforvancomycinapilotstudy
AT karenwhitfield thedevelopmentimplementationandevaluationofapharmacistmanagedtherapeuticdrugmonitoringtdmserviceforvancomycinapilotstudy
AT paulfirman developmentimplementationandevaluationofapharmacistmanagedtherapeuticdrugmonitoringtdmserviceforvancomycinapilotstudy
AT kensoontan developmentimplementationandevaluationofapharmacistmanagedtherapeuticdrugmonitoringtdmserviceforvancomycinapilotstudy
AT alexandraclavarino developmentimplementationandevaluationofapharmacistmanagedtherapeuticdrugmonitoringtdmserviceforvancomycinapilotstudy
AT mengwongtaing developmentimplementationandevaluationofapharmacistmanagedtherapeuticdrugmonitoringtdmserviceforvancomycinapilotstudy
AT sallydixon developmentimplementationandevaluationofapharmacistmanagedtherapeuticdrugmonitoringtdmserviceforvancomycinapilotstudy
AT helendersingh developmentimplementationandevaluationofapharmacistmanagedtherapeuticdrugmonitoringtdmserviceforvancomycinapilotstudy
AT karenwhitfield developmentimplementationandevaluationofapharmacistmanagedtherapeuticdrugmonitoringtdmserviceforvancomycinapilotstudy